Last reviewed · How we verify

NCT06228833

A Clinical Study to Evaluate the Efficacy and Safety of Monopolar Radiofrequency Combined With SkinCeuticals A.G.E and Skinceuticals CE FERULIC for Improving Facial Skin Elasticity, Tightening and Fading Fine Lines

Status unknown NA Last updated 29 January 2024
What this trial tests

NA trial testing monopolar radiofrequency in Skin Aging in 50 participants. Status unknown.

Timeline
30 January 2024
Primary endpoint
30 March 2024
30 October 2024

Quick facts

Lead sponsorYes Skin Medical Group
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment50
Start date30 January 2024
Primary completion30 March 2024
Estimated completion30 October 2024

Drugs / interventions tested

Conditions studied

Sponsor

Yes Skin Medical Group

Who can join

Adults 25 to 65, female only, with Skin Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Prospective, Single-center, Single-blind, Randomized split-face, controlled trial will be conducted. The goal of this clinical trial is to evaluate the efficacy and safety of monopolar radiofrequency combined with SkinCeuticals A.G.E and Skinceuticals CE FERULIC for improving facial skin elasticity, tightening and fading fine lines

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical Measurement of Transepidermal Water Loss.
    Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148

Verify or expand the search:

Other recruiting trials for Skin Aging

Currently open trials in the same condition.

Other Yes Skin Medical Group trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06228833.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing